Grant projects

Current Projects

  • VEGA 1/0305/24 “Exogenous Pulmonary Surfactant for the Delivery of Antiviral Drugs: Interactions and Structural Stability”

Principal Investigator: Prof. RNDr. D. Uhríková, CSc.

  • APVV-SK-FR-24-0011 “The Role of Natural Antioxidants in Damage to Biological Membranes Caused by Oxidative Stress” (bilateral cooperation grant with the University of Paris-Saclay, France)

Principal Investigator for Slovakia: Prof. RNDr. D. Uhríková, CSc.

Principal Investigator for France: Dr. Angelina Angelova, PhD, H.D.R.

Grant projects completed over the past 5 years

  • APVV-21-0108 “Antiviral Drugs Against COVID-19: Design, Synthesis, and Activity Testing of Specific Inhibitors of SARS-CoV-2 Viral Proteases”

Principal Investigator: Prof. Ing. V. Frecer, DrSc.

Principal Investigator: Assoc. Prof. Nadica Ivošević de Nardis, PhD., Division for Marine and Environmental Research, Ruder Bosković Institute, Zagreb, Croatia

Principal Investigator for the Slovak Republic: Mgr. M. Klacsová, PhD.

  • APVV-17-0250 “Pulmonary Surfactant as a Modulator of the Body’s Response to Endotoxin Exposure: Effects and Mechanisms”

Principal Investigator: Prof. MUDr. A. Čalkovská, DrSc., Jessenius Faculty of Medicine in Martin, Comenius University;

Principal Investigator for the Faculty of Pharmacy, Comenius University (collaborating institution): Prof. RNDr. D. Uhríková, CSc.

  • APVV-17-0239 “Computer-Aided Design, Synthesis, Testing, and Screening of Influenza A Virus Neuraminidase Inhibitors as Potential Antiviral Agents”

Principal Investigator: Prof. Ing. V. Frecer, DrSc.

  • VEGA 1/0223/20 “Lipid bilayer in pulmonary surfactant models: interactions and targeted drug delivery”

Principal Investigator: Prof. RNDr. D. Uhríková, CSc.

  • APVV SK-PT-18-0032 “Phospholipid Membranes—Site of Action of Antimicrobial Agents”

Principal Investigator for Slovakia: Prof. RNDr. D. Uhríková, CSc.

Principal Investigator for Portugal: Assoc. Prof. M. Bastos, PhD.

Grant Projects at International Research Centers (2021–2026)

  • 8-02-1080 “Cathelicidin–enriched exogenous lung surfactant: the effect of hydrophobicity,” ILL Grenoble, SAND experiment, 2026

Principal Investigator: Prof. RNDr. D. Uhríková, CSc.

  • 20250340328 “Lipid-based delivery vehicles for antivirals against the SARS-CoV-2 coronavirus – continuation,” ALBA Barcelona, Spain, SAXS/WAXS experiment, 2025

Principal Investigator: Prof. RNDr. D. Uhríková, CSc.

  • 8-02-1057 “The charge of the lipid membrane and its rigidity determine the antimicrobial effect of polymyxin B,” ILL Grenoble, SAND experiment, 2025

Principal Investigator: Prof. RNDr. D. Uhríková, CSc.

  • 8-02-1032 “Does budesonide affect the structure of pulmonary surfactant?”, ILL Grenoble, France, SAND experiment, 2024

Principal Investigator: Prof. RNDr. D. Uhríková, CSc.

  • 2023027497 “Lamellar stability of cathelicidins-enriched exogenous pulmonary surfactant: the effect of bacterial endotoxin,” ALBA Barcelona, Spain, SAXS/WAXS experiment, 2023

Principal Investigator: Prof. RNDr. D. Uhríková, CSc.

  • BRR-681 “Liposomal delivery system for inhibitors of viral proteases of the SARS-CoV-2 coronavirus,” BNC Budapest, Hungary, SANS experiment, 2022

Principal Investigator: Prof. RNDr. D. Uhríková, CSc.

  • 2022025753 “Fusion-mediated viral entry: Investigation of potential SARS-CoV-2 antivirals on the structural stability of model membranes,” ALBA Barcelona, Spain, SAXS/WAXS experiment, 2022

Principal Investigator: Mgr. M. Klacsová, PhD.

  • 2021025016 “Lipid-based delivery system for inhibitors of viral proteases of the SARS-CoV-2 coronavirus,” ALBA Barcelona, Spain, SAXS/WAXS experiment, 2021

Principal Investigator: Prof. RNDr. D. Uhríková, CSc.

  • 8-02-927 “Phospholipid bilayer of pulmonary surfactant: the effect of lipopolysaccharide and polymyxin B,” ILL Grenoble, France, SAND experiment, 2021

Principal Investigator: Prof. RNDr. D. Uhríková, CSc.